\-\ Texto\\:\\ \ \(0\)\
\-\ obese\\.\\ walks\\ with\\ difficulty\\.\\ \\ no\\ crepitus\\ in\\ the\\ hips\\.\ \(0\)\
\-\ \\â\\€\\¢\\ \\"beaking\\"\\ on\\ the\\ lateral\\ cortex\\ of\\ the\\ infratrochanteric\\ portion\\ of\\ each\\ femoral\\ shaft\\,\\ opposite\\ the\\ lesser\\ trochanters\ \(1\)\
\-\ bisphosphanate\\-related\\ stress\\ fractures\\ of\\ the\\ femur\ \(0\)\
\-\ 63\\ y\\.o\\.\\ woman\\ with\\ an\\ insidious\\ onset\\ of\\ bilateral\\ hip\\ area\\ pain\\ for\\ 3\\-4\\ months\\.\\ she\\ has\\ a\\ history\\ of\\ rheumatoid\\ arthritis\\ treated\\ by\\ steroids\\,\\ and\\ osteoporosis\\ treated\\ by\\ risedronate\\ \\(actonel\\)\\.\ \(0\)\
\-\ source\\ \\-\\ http\\:\\/\\/www\\.ncbi\\.nlm\\.nih\\.gov\\/pubmedhealth\\/pmh0000178\ \(0\)\
\-\ \\"fda\\ notified\\ healthcare\\ professionals\\ and\\ patients\\ that\\ at\\ this\\ point\\,\\ the\\ data\\ that\\ fda\\ has\\ reviewed\\ have\\ not\\ shown\\ a\\ clear\\ connection\\ between\\ bisphosphonate\\ use\\ and\\ a\\ risk\\ of\\ atypical\\ subtrochanteric\\ femur\\ fractures\\.\\ fda\\ is\\ working\\ with\\ outside\\ experts\\,\\ including\\ members\\ of\\ the\\ recently\\ convened\\ american\\ society\\ of\\ bone\\ and\\ mineral\\ research\\ subtrochanteric\\ femoral\\ fracture\\ task\\ force\\,\\ to\\ gather\\ more\\ information\\ and\\ evaluate\\ the\\ issue\\ further\\.\\"\ \(0\)\
\-\ http\\:\\/\\/en\\.wikipedia\\.org\\/wiki\\/risedronic\\_acid\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ fda\\:\\ 0\\.35383262770492413\ \(0\)\
\-\ subtrochanteric\\:\\ 0\\.2478083620655371\ \(0\)\
\-\ femur\\:\\ 0\\.13757969823537228\ \(0\)\
\-\ infratrochanteric\\:\\ 0\\.1340928201172334\ \(0\)\
\-\ risedronate\\:\\ 0\\.1340928201172334\ \(0\)\
\-\ actonel\\:\\ 0\\.1340928201172334\ \(0\)\
\-\ convened\\:\\ 0\\.1340928201172334\ \(0\)\
\-\ gather\\:\\ 0\\.1340928201172334\ \(0\)\
\-\ the\\:\\ 0\\.1338473250353584\ \(0\)\
\-\ of\\:\\ 0\\.1312710401515576\ \(0\)\
\-\ healthcare\\:\\ 0\\.12813284831943955\ \(0\)\
\-\ experts\\:\\ 0\\.12813284831943955\ \(0\)\
\-\ femoral\\:\\ 0\\.1246400617327272\ \(0\)\
\-\ fractures\\:\\ 0\\.12397940026314187\ \(0\)\
\-\ http\\:\\ 0\\.12397940026314187\ \(0\)\
\-\ trochanters\\:\\ 0\\.12390418103276855\ \(0\)\
\-\ professionals\\:\\ 0\\.1206241718628119\ \(0\)\
\-\ notified\\:\\ 0\\.1179442092349747\ \(0\)\
\-\ bisphosphonate\\:\\ 0\\.1179442092349747\ \(0\)\
\-\ mineral\\:\\ 0\\.1156783331188574\ \(0\)\
\-\ task\\:\\ 0\\.11371554194830373\ \(0\)\
\-\ walks\\:\\ 0\\.11043553277834704\ \(0\)\
\-\ beaking\\:\\ 0\\.10657901445973986\ \(0\)\
\-\ treated\\:\\ 0\\.10443029511765195\ \(0\)\
\-\ society\\:\\ 0\\.1035269028638389\ \(0\)\
\-\ members\\:\\ 0\\.10263577554103734\ \(0\)\
\-\ insidious\\:\\ 0\\.1002468936938822\ \(0\)\
\-\ issue\\:\\ 0\\.1002468936938822\ \(0\)\
\-\ opposite\\:\\ 0\\.09884591991755198\ \(0\)\
\-\ crepitus\\:\\ 0\\.09819251905521756\ \(0\)\
\-\ research\\:\\ 0\\.09819251905521756\ \(0\)\
\-\ reviewed\\:\\ 0\\.09696688452392552\ \(0\)\
\-\ working\\:\\ 0\\.09428692189608834\ \(0\)\
\-\ lesser\\:\\ 0\\.09160695926825117\ \(0\)\
\-\ connection\\:\\ 0\\.09120421903195423\ \(0\)\
\-\ force\\:\\ 0\\.09043040357748115\ \(0\)\
\-\ osteoporosis\\:\\ 0\\.08934108315213386\ \(0\)\
\-\ hips\\:\\ 0\\.08832695009829447\ \(0\)\
\-\ shaft\\:\\ 0\\.08800387997075271\ \(0\)\
\-\ obese\\:\\ 0\\.08677824543946068\ \(0\)\
\-\ and\\:\\ 0\\.08663185623153762\ \(0\)\
\-\ information\\:\\ 0\\.0829217271208535\ \(0\)\
\-\ data\\:\\ 0\\.08225849737210766\ \(0\)\
\-\ 63\\:\\ 0\\.0810155799474894\ \(0\)\
\-\ source\\:\\ 0\\.07986961552495253\ \(0\)\
\-\ each\\:\\ 0\\.07950665636592866\ \(0\)\
\-\ has\\:\\ 0\\.07659956873690671\ \(0\)\
\-\ rheumatoid\\:\\ 0\\.07390964372715866\ \(0\)\
\-\ steroids\\:\\ 0\\.07366667788004524\ \(0\)\
\-\ recently\\:\\ 0\\.07319247226987516\ \(0\)\
\-\ that\\:\\ 0\\.07277465127893962\ \(0\)\
\-\ american\\:\\ 0\\.0715391472471041\ \(0\)\
\-\ by\\:\\ 0\\.07121430488616154\ \(0\)\
\-\ difficulty\\:\\ 0\\.07053196576543523\ \(0\)\
\-\ point\\:\\ 0\\.06931801728146382\ \(0\)\
\-\ stress\\:\\ 0\\.06922866078087177\ \(0\)\
\-\ atypical\\:\\ 0\\.06878984911768614\ \(0\)\
\-\ cortex\\:\\ 0\\.06828000266415746\ \(0\)\
\-\ arthritis\\:\\ 0\\.06819672142675606\ \(0\)\
\-\ outside\\:\\ 0\\.06731047996043313\ \(0\)\
\-\ evaluate\\:\\ 0\\.06520181495873818\ \(0\)\
\-\ shown\\:\\ 0\\.06499999349420078\ \(0\)\
\-\ hip\\:\\ 0\\.0644106410952089\ \(0\)\
\-\ use\\:\\ 0\\.06415610488076678\ \(0\)\
\-\ clear\\:\\ 0\\.06078803922704559\ \(0\)\
\-\ including\\:\\ 0\\.06000650770988585\ \(0\)\
\-\ portion\\:\\ 0\\.05995901461822783\ \(0\)\
\-\ risk\\:\\ 0\\.059911674483651596\ \(0\)\
\-\ further\\:\\ 0\\.05461226650290754\ \(0\)\
\-\ between\\:\\ 0\\.05448102367494327\ \(0\)\
\-\ area\\:\\ 0\\.05431860103801266\ \(0\)\
\-\ onset\\:\\ 0\\.0538418317060116\ \(0\)\
\-\ she\\:\\ 0\\.04991331765613932\ \(0\)\
\-\ with\\:\\ 0\\.049256052962537995\ \(0\)\
\-\ months\\:\\ 0\\.04880690724039976\ \(0\)\
\-\ fracture\\:\\ 0\\.04765428310359936\ \(0\)\
\-\ patients\\:\\ 0\\.04716965352413819\ \(0\)\
\-\ more\\:\\ 0\\.04604207446870189\ \(0\)\
\-\ bone\\:\\ 0\\.045750632969505975\ \(0\)\
\-\ bilateral\\:\\ 0\\.0450635517972044\ \(0\)\
\-\ woman\\:\\ 0\\.043668838284631736\ \(0\)\
\-\ have\\:\\ 0\\.041887179477813986\ \(0\)\
\-\ lateral\\:\\ 0\\.041612421962641255\ \(0\)\
\-\ not\\:\\ 0\\.033101594378058055\ \(0\)\
\-\ an\\:\\ 0\\.0320635797607517\ \(0\)\
\-\ history\\:\\ 0\\.032035175695718864\ \(0\)\
\-\ at\\:\\ 0\\.03167083237556769\ \(0\)\
\-\ pain\\:\\ 0\\.030004261340292996\ \(0\)\
\-\ this\\:\\ 0\\.028812029649211698\ \(0\)\
\-\ no\\:\\ 0\\.027266743783062358\ \(0\)\
\-\ for\\:\\ 0\\.02541399125457148\ \(0\)\
\-\ on\\:\\ 0\\.02532384010366015\ \(0\)\
\-\ is\\:\\ 0\\.022962620912785617\ \(0\)\
\-\ to\\:\\ 0\\.020962087661616228\ \(0\)\
\-\ in\\:\\ 0\\.02085891230955973\ \(0\)\
